Metabolic Wellness Considerations In Schizophrenia

Dr. Wirshing is a Clinical Professor of Psychiatry at the Keck School of Medicine at USC and is Medical Director of Exodus Recovery Inc. in Los Angeles, CA. He has for several decades studied the treatment of persons with schizophrenia. His particular areas of interest have been on the efficacies and toxicities of both conventional and atypical antipsychotic compounds. While at UCLA his group was the first to identify the curious metabolic toxicities of certain antipsychotic compounds and to correctly speculate on a specific causal pharmacologic characteristic. The current focus of his interest is providing improved crisis care to the seriously mentally ill throughout California.

Dri Wang, PharmD, BCPP is a Medical Science Liaison for Otsuka Pharmaceutical, Development & Commercialization, Inc.